LGVN - Longeveron surges on key FDA designation for Alzheimer's drug
2024-07-10 09:53:04 ET
More on Longeveron
- Longeveron Inc. (LGVN) Q1 2024 Earnings Call Transcript
- Longeveron announces exercise of warrants for $4.4M gross proceeds
- Longeveron announces launch of contract development and manufacturing business
- Seeking Alpha’s Quant Rating on Longeveron
- Historical earnings data for Longeveron